Linezolid does not show advantages over vancomycin in modulating the pulmonary immune response

How should we conciliate these new findings with the Zephyr trial results?

Research output: Contribution to journalEditorial

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)2009-2010
Number of pages2
JournalCritical care medicine
Volume39
Issue number8
DOIs
StatePublished - Aug 1 2011

Fingerprint

Linezolid
Acetamides
Inbred BALB C Mouse
Staphylococcal Pneumonia
Oxazolidinones
Animal Disease Models
Vancomycin
Methicillin-Resistant Staphylococcus aureus
Anti-Infective Agents
Innate Immunity
Pneumonia
Anti-Bacterial Agents
Lung

Keywords

  • Linezolid
  • pneumonia
  • vancomycin

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

@article{31319eb02d7e4685aa17aa9928979f06,
title = "Linezolid does not show advantages over vancomycin in modulating the pulmonary immune response: How should we conciliate these new findings with the Zephyr trial results?",
keywords = "Linezolid, pneumonia, vancomycin",
author = "Kalil, {Andre C}",
year = "2011",
month = "8",
day = "1",
doi = "10.1097/CCM.0b013e318221741c",
language = "English (US)",
volume = "39",
pages = "2009--2010",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Linezolid does not show advantages over vancomycin in modulating the pulmonary immune response

T2 - How should we conciliate these new findings with the Zephyr trial results?

AU - Kalil, Andre C

PY - 2011/8/1

Y1 - 2011/8/1

KW - Linezolid

KW - pneumonia

KW - vancomycin

UR - http://www.scopus.com/inward/record.url?scp=79961086745&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79961086745&partnerID=8YFLogxK

U2 - 10.1097/CCM.0b013e318221741c

DO - 10.1097/CCM.0b013e318221741c

M3 - Editorial

VL - 39

SP - 2009

EP - 2010

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 8

ER -